Abstract | PURPOSE: EXPERIMENTAL DESIGN: A functional RNAi screen targeting human RTKs and related growth factors was used to identify candidate RTKs conferring lapatinib unresponsiveness in HER2+ gastric cancer cells. Independent siRNAs transfection and corresponding ligands supplement were performed to validate the effects of candidate RTKs on lapatinib sensitivity. Cross-talks of pathways involved were analyzed via Western blot analysis. Cell apoptosis and cell motility were detected using FACS system and Transwell assay. Immunohistochemistry was used to analyze protein expression in clinical samples. RESULTS: MET, HER3, insulin-like growth factor (IGF)-1R, and INSR were identified to mediate lapatinib unresponsiveness in HER2+ gastric cancer cells. Activation of these bypass RTKs attenuated lapatinib-induced apoptosis and suppression of cell motility, mechanistically because of restimulating the shared downstream AKT or ERK signaling, as well as restimulating WNT signaling and epithelial-to-mesenchymal transition (EMT)-like process. Patients' specimens revealed that these unresponsiveness-conferring RTKs were particularly enriched in the majority of patients with HER2+ gastric cancer. CONCLUSIONS: MET, HER3, IGF1R, and INSR pathways activation represent novel mechanism underlying lapatinib unresponsiveness in HER2+ gastric cancer. Combination strategy may be recommended in treating patients with HER2+ gastric cancer with these pathways activation.
|
Authors | Zhe Zhang, Jiping Wang, Dongmei Ji, Chenchen Wang, Rujiao Liu, Zheng Wu, Lian Liu, Dan Zhu, Jinjia Chang, Ruixuan Geng, Lei Xiong, Qiangyi Fang, Jin Li |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 20
Issue 17
Pg. 4559-73
(Sep 01 2014)
ISSN: 1557-3265 [Electronic] United States |
PMID | 24973425
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | ©2014 American Association for Cancer Research. |
Chemical References |
- Antigens, CD
- Quinazolines
- Lapatinib
- ERBB2 protein, human
- ERBB3 protein, human
- INSR protein, human
- Proto-Oncogene Proteins c-met
- Receptor, ErbB-2
- Receptor, ErbB-3
- Receptor, IGF Type 1
- Receptor, Insulin
|
Topics |
- Antigens, CD
(genetics)
- Apoptosis
- Cell Line, Tumor
- Drug Resistance, Neoplasm
(genetics)
- Female
- Humans
- Lapatinib
- Middle Aged
- Proto-Oncogene Proteins c-met
(genetics)
- Quinazolines
(administration & dosage)
- Receptor, ErbB-2
(genetics)
- Receptor, ErbB-3
(genetics)
- Receptor, IGF Type 1
(genetics)
- Receptor, Insulin
(genetics)
- Signal Transduction
- Stomach Neoplasms
(drug therapy, genetics, pathology)
|